Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.43B |
| 2 |
Chevron
CVX
|
+$314M |
| 3 |
ExxonMobil
XOM
|
+$282M |
| 4 |
Tesla
TSLA
|
+$253M |
| 5 |
Warner Bros
WBD
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$278M |
| 2 |
CERN
Cerner Corp
CERN
|
+$275M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$149M |
| 4 |
Baidu
BIDU
|
+$137M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Bridgewater Bancshares
BWB
$592M
| $31K | ﹤0.01% |
1,913
+77
| +4% | +$1.24K |
|
3102
Beazer Homes USA
BZH
$915M
| $31K | ﹤0.01% |
2,571
-213
| -8% | -$3.11K |
|
3103
MetroCity Bankshares
MCBS
$1.03B
| $31K | ﹤0.01% |
1,528
-111
| -7% | -$2.3K |
|
3104
Praxis Precision Medicines
PRAX
$10.3B
| $31K | ﹤0.01% |
849
+322
| +61% | +$34.4K |
|
3105
RxSight
RXST
$253M
| $31K | ﹤0.01% |
2,213
+440
| +25% | +$5.8K |
|
3106
Southern Missouri Bancorp
SMBC
$858M
| $31K | ﹤0.01% |
676
+91
| +16% | +$4.12K |
|
3107
SmartFinancial
SMBK
$901M
| $31K | ﹤0.01% |
1,272
+162
| +15% | +$4.03K |
|
|
KNTE
3108
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $31K | ﹤0.01% |
2,486
-1,739
| -41% | -$16.2K |
|
|
DZSI
3109
DELISTED
DZS Inc. Common Stock
DZSI
| $31K | ﹤0.01% |
1,883
+366
| +24% | +$5.39K |
|
|
CTO
3110
CTO Realty Growth
CTO
$817M
| $30K | ﹤0.01% |
1,452
+66
| +5% | +$1.39K |
|
3111
Citizens & Northern Corp
CZNC
$453M
| $30K | ﹤0.01% |
1,234
+68
| +6% | +$1.65K |
|
3112
Foghorn Therapeutics
FHTX
$331M
| $30K | ﹤0.01% |
2,222
+557
| +33% | +$7.19K |
|
3113
Financial Institutions
FISI
$827M
| $30K | ﹤0.01% |
1,153
-116
| -9% | -$3.23K |
|
3114
GCM Grosvenor
GCMG
$814M
| $30K | ﹤0.01% |
4,418
-111
| -2% | -$905 |
|
3115
Ooma
OOMA
$588M
| $30K | ﹤0.01% |
2,558
+60
| +2% | +$796 |
|
|
VTYX
3116
DELISTED
Ventyx Biosciences
VTYX
| $30K | ﹤0.01% |
2,422
+1,462
| +152% | +$21.8K |
|
|
DSKE
3117
DELISTED
Daseke, Inc. Common Stock
DSKE
| $30K | ﹤0.01% |
4,641
+508
| +12% | +$3.88K |
|
|
AMNB
3118
DELISTED
American National Bankshares Inc
AMNB
| $30K | ﹤0.01% |
876
+44
| +5% | +$1.56K |
|
3119
Celularity
CELU
$19.8M
| $29K | ﹤0.01% |
+859
| New | +$69.8K |
|
3120
Vita Coco
COCO
$3.71B
| $29K | ﹤0.01% |
3,008
+1,824
| +154% | +$19.3K |
|
|
DFTX
3121
Definium Therapeutics
DFTX
$6.12B
| $29K | ﹤0.01% |
2,993
-2,644
| -47% | -$33.5K |
|
|
OGI
3122
Organigram Holdings
OGI
$139M
| $29K | ﹤0.01% |
8,019
| – | – |
|
3123
Southern First Bancshares
SFST
$604M
| $29K | ﹤0.01% |
660
+34
| +5% | +$1.54K |
|
3124
Arbutus Biopharma
ABUS
$897M
| $28K | ﹤0.01% |
10,466
+2,515
| +32% | +$6.44K |
|
3125
Distribution Solutions Group
DSGR
$1.61B
| $28K | ﹤0.01% |
1,084
+18
| +2% | +$375 |
|
Similar funds
Legal & General Group's Q2 2022 Portfolio in Review
As of Q2 2022, Legal & General Group held 3,787 positions worth $283B, down 14% from $329B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group's Q2 2022 filing shows 222 new, 1,979 increased, 1,147 reduced and 274 closed positions. Its largest new stake was Samsara: 1,199,080 shares worth $13.4M. The largest sale was AT&T, an estimated $278M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2022 buy was Samsara: 1,199,080 shares worth $13.4M.
- Legal & General Group added most to Apple in Q2 2022, an estimated $1.43B increase.
- Legal & General Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $278M.
- Legal & General Group fully exited Cerner Corp in Q2 2022, selling an estimated $275M.
- Legal & General Group's ten largest holdings make up 22% of its $283B portfolio in Q2 2022.
- Legal & General Group opened 222 new positions and closed 274 in Q2 2022.
- Legal & General Group's portfolio value fell 14% quarter-over-quarter to $283B.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.